Biotech Daily covers the major announcements from ASX-listed biotech companies as well as developments in government policy and regulation.

Published shortly after the stock market closes five days a week - excluding public holidays - Biotech Daily is the only comprehensive daily source of information on the listed biotech sector.

A Top 40 of the more than 100 listed companies is constantly monitored for clinical development and price sensitive announcements and published via direct subscription as well as through Factiva's more than two million screens in the US, Europe, Asia and the Pacific. Sample copies of Biotech Daily appear below.

Subscriptions are $A640 a year (including GST in Australia) and a 10% discount is available for members of the Bio-Melbourne Network.

Subscribers include biotech CEOs and CFOs, investment houses, market analysts, retail investors, doctors, medical specialists and hospital management. 

Please fill in the subscription form below.